Does the liver clear estrogens and can hepatic fat/inflammation reduce that clearance leading to higher estradiol in men?

Estrogens are primarily cleared by the liver through a highly coordinated, sequential metabolic pathway that regulates systemic exposure.

Hepatic clearance mechanisms

• Phase I oxidation: Cytochrome P450 enzymes—predominantly CYP1A2 and CYP3A4—catalyze the hydroxylation of parent estrogens (estradiol and estrone) at the 2-, 4-, and 16α-positions, preparing them for downstream conjugation. Notably, circulating estrogens can upregulate and induce CYP3A4 expression as a feedback mechanism.
• Phase II conjugation: Cytosolic estrogen sulfotransferase (SULT1E1) and UDP-glucuronosyltransferases (including UGT1A1, UGT1A9, and UGT2B7) convert these intermediates into water-soluble, biologically inactive conjugates, facilitating their excretion via bile and urine.

Impact of hepatic fat and inflammation

• Enzymatic downregulation: Hepatic steatosis and inflammation, characteristic of nonalcoholic fatty liver disease (NAFLD), significantly suppress the expression and metabolic activity of CYP3A4 in human liver tissue.
• Systemic endocrine complexity: While impaired CYP3A4 activity provides a plausible mechanism for reduced estrogen clearance, its direct clinical impact on male serum estradiol is highly confounded. Elevated estradiol in men with metabolic dysfunction is often primarily driven by the peripheral aromatization of testosterone in adipose tissue. Conversely, some cohorts of men with NAFLD show decreased total estradiol and testosterone levels due to systemic hypothalamic-pituitary-gonadal axis suppression and reduced sex hormone-binding globulin (SHBG).

Bottom line

• The liver clears estrogens via Phase I (CYP) and Phase II (SULT/UGT) pathways, and hepatic fat/inflammation impairs this clearance by downregulating CYP3A4; however, whether this clearance deficit directly raises serum estradiol in men remains difficult to isolate from confounding obesity-driven peripheral aromatization and systemic endocrine changes.